Skip to content
Be The Match BioTherapies
When patients’ lives are at the heart of what you do, experience matters.
Be The Match BioTherapiesBe The Match BioTherapies
  • Solutions
    • Allogeneic Cell Sourcing
    • Cord Blood Units
    • Research Use Only
    • Bioinformatics Consulting
    • CIBMTR CRO Services
    • Autologous Supply Chain Management
    • Collection Network Onboarding
    • Collection Network Management
    • Quality System Audit Program
    • Outcomes Data Collection and Analysis
  • About Us
    • History
    • Leadership
    • Partners
    • Newsroom
    • Join Our Team
  • Cell Lines Blog
  • Resources
Search:
CONTACT US
  • Home
  • Solutions
    • Allogeneic Cell Sourcing
    • Cord Blood Units
    • Research Use Only
    • CIBMTR CRO Services
    • Bioinformatics Consulting
    • Autologous Supply Chain Management
    • Collection Network Onboarding
    • Collection Network Management
    • Quality System Audit Program
    • Outcomes Data Collection and Analysis
  • About Us
    • History
    • Leadership
    • Our Partners
    • Newsroom
    • Join Our Team
  • Cell Lines Blog
  • Resources
  • Contact Us

Cell Lines Blog

An online resource for navigating the complexities of cell sourcing, supply chain and clinical development.

View allAllogeneic Cell SourcingFeaturedIndustry StandardizationIndustry UpdatesOutcomes ReportingSupply Chain
Jan312023

International regulations for allogeneic cell source material

Read more
Dec122022

4 benefits of cord blood for allogeneic cell therapies

Read more
Aug252022

HLA, histocompatibility and the science of cell source selection

Read more
May312022

Behind the scenes of a cell therapy transport

Read more
Mar152022

The value of cord blood as an allogeneic source material

Read more
Mar12022

Effect of rapid cell therapy growth on collection capacity

Read more
Feb82022

A defining year for advancements in cell and gene therapy

Read more
Dec292021

The promise allogeneic NK cell and iPSC therapies hold

Read more
Nov152021
Cell and gene therapy logistics blog header image

Which cell therapy supply chain changes are here to stay?

Read more
Sep302021

Creating scalable cell therapy collection processes

Read more
Aug102021

Strategies for successful commercial-readiness in gene therapy

Read more
Apr292021

Another record year for cell and gene therapies?

Read more
Apr132021
Martin Maiers is the Vice President of Innovation at the NMDP/Be The Match

HLA’s future impact on allogeneic cell therapy development

Read more
Mar42021

Supporting transformational treatments for rare disorders

Read more
Jan272021

Advancements in cell and gene therapy

Read more
Jan132021

Transforming patient care through cell and gene therapy

Read more
Dec172020
Erin Rasch, Vice President of Sales and Business Development for Be The Match BioTherapies

Maintaining business continuity during COVID-19

Read more
Dec32020

A roundup of COVID-19 treatments in development

Read more
Oct222020

6 considerations when evaluating cell sourcing vendors

Read more
Oct142020

Scaling cell therapy supply chains during a pandemic

Read more
Sep252020

Being an NMDP/Be The Match courier during COVID-19

Read more
Sep92020
Depiction of a patient receiving CAR-T therapy

How CAR-T reimbursement discussions help advance the field

Read more
Aug272020
Amy Ronneberg is the CEO of Be The Match BioTherapies

Be The Match BioTherapies CEO’s path to biotech

Read more
Jul302020

5 qualities to seek in your cell therapy supply chain vendor

Read more
Jun92020
Depiction of international autologous cell therapy logistics.

Overcoming autologous cell therapy logistics challenges in the age of COVID-19

Read more
May292020
Illustration of a stormy sea to represent cytokine storm.

Can cell therapies unlock the COVID-19 mystery?

Read more
May212020
Representation of cell therapy production disruption due to COVID-19 pandemic

How COVID-19 is changing the production of cell therapies

Read more
Apr102020
Representation of NMDP/Be The Match donor collection network

Managing donor collections during the COVID-19 pandemic

Read more
Mar122020
Super donors definition, which is individuals who frequently donate their cells.

The role of ‘super donors’ in cell therapy scalability

Read more
Feb202020
COVID-19

Navigating a time-sensitive cell therapy supply chain during the coronavirus outbreak (Updated)

Read more
Feb102020

HLA matching could bring more allogeneic cell therapies to market, faster

Read more
Jan82020
2019 year-in-review

Advancements in cell and gene therapy: 2019 year-in-review

Read more
Dec202019

Quality starting material: The driving force behind life-saving cell therapies

Read more
Dec52019
Featured Image Icon

Cell collection standards for cell therapies

Read more
Nov62019

How to overcome 3 common cell therapy supply chain disruptions

Read more
Oct92019

Overcoming challenges to cellular starting material collection

Read more
Aug292019
Abby McDonald, PhD, is the manager of Solutions Development at Be The Match BioTherapies

Driving CAR-T therapy safety and sustainability for the road ahead

Read more
Aug72019
Starting Material

An opportunity to impact the future of medicine

Read more
Jul112019

The benefits of a Quality System Audit Program

Read more
Jun202019

Standardization in cell therapy industry is a race against time

Read more
May62019
Arrows guiding you to overcome your challenges

The challenge of multiple audits and redundant training

Read more
Mar132019

Industry stakeholders propose unified CAR T toxicity grading scale

Read more
Feb282019
Efficiencies gained from the Quality System Audit Program

Three things to know about efficient qualification of collection centers

Read more
Feb52019
Ray Hornung, the Senior Manager of Logistics and Emergency Preparedness for Be The Match BioTherapies and the National Marrow Donor Program/Be The Match

‘There is no room for error’ in cell and gene therapy logistics

Read more
Jan112019
Cell Therapy Year-in-Review 2018

Advancements in cell therapy: 2018 year-in-review

Read more
Dec52018

How standardizing audits can help deliver high-quality therapies faster

Read more
Nov282018
Amy Hines, director of Collection Network Management, Be The Match BioTherapies

Q&A with Amy Hines, director of Collection Network Management

Read more
Nov72018

The need for a standardized audit approach

Read more
Oct302018
Petr Machalik, an International Collection Network Manager at Be The Match BioTherapies.

Q&A with International Collection Network Manager, Petr Machalik

Read more
Oct182018

Reimbursement uncertainties hinder patient access to CAR-T therapies

Read more
Aug272018
Read our review of the updated FDA guidances for gene therapy regulations

FDA aims to update gene therapy regulations with new draft guidances

Read more
Aug212018
Stem cell therapy

Cell therapy in 2018: Mid-year review

Read more
Jul262018

As CAR-T therapies mature, researchers begin to track long-term patient outcomes

Read more
Jun262018
Hand holding a bag of cord blood

The expanding potential of cord blood

Read more
Jun202018
car-t cell

CAR-T 2.0

Read more
Jun132018
Woman during an apheresis collection and an apheresis registered nurse.

The crucial role in delivering effective cell and gene therapies

Read more
Jun52018

Top industry stakeholders gather for standardization summit

Read more
May222018
Jamie Margolis

Q&A with Be The Match BioTherapies Director of Product Development Operations, Dr. Jamie Margolis

Read more
May72018
Chris McClain

Q&A with Chris McClain, VP of New Business Development and Sales

Read more
May12018

Techniques for Navigating the Cell Therapy Supply Chain

Read more
Mar272018
Dr. Steven Devine

Q&A with Be The Match BioTherapies Medical Director, Dr. Steven Devine

Read more
Feb232018

Q&A with Be The Match BioTherapies President, Amy Ronneberg

Read more
Feb142018

Supply chain concerns get attention at Cell & Gene Therapy World

Read more
Jan302018
Read our review of the updated FDA guidances for gene therapy regulations

What do the new FDA guidance documents mean for the industry?

Read more
Jan182018

The future of cell therapy: challenges & solutions

Read more
Jan32018

Better match, better outcome: When it comes to UCB transplant, the precision of the match is important

Read more
Dec272017
Cell and gene therapy industry news

2017: cell therapy year-in-review

Read more
Dec142017

HLA in the age of CRISPR

Read more
Nov142017
Successful cell therapy delivery depends on well-designed supply chains, backed by contingency plans.

You never know… contingency planning in the cell therapy supply chain

Read more
Oct312017

Getting under the hood of Be The Match BioTherapies’ powerful search engine

Read more
Load more
Be The Match Logo

How to Reach Us
(800) 471-4431
Email Us

Where We’re Located
500 N 5th Street
Minneapolis, MN 55401

LinkedIn Icon   Twitter Icon   YouTube Icon

Solutions

Adult Allogeneic Cell Sourcing
Cord Blood Unit Sourcing
Bioinformatics Consulting
CIBMTR CRO Services
RUO Cellular Source Material
Autologous Supply Chain Management

About Us

History
Leadership
Partners
Newsroom
Join Our Team

Cell Lines Blog



Resources

Copyright © 2021 Be The Match BioTherapies. All Rights Reserved.
  • Terms of Use
  • Privacy Policy
  • Trademark & Copyright
  • Contact
Footer Menu
Go to Top